BASF further delays vitamin and carotenoid production restart

By Jane Byrne

- Last updated on GMT

Section of BASF's Ludwigshafen site in Germany © BASF
Section of BASF's Ludwigshafen site in Germany © BASF
BASF has announced a further delay to the resumption of vitamin and carotenoid production following the incident earlier this year at its Ludwigshafen site in Germany.

On July 29, an explosion and subsequent fire occurred at a plant in the southern section of the chemical complex, which produces aroma ingredients and key precursors for vitamins.

The fire​ caused significant damage, forcing the plant's shutdown and leading BASF to declare force majeure on the supply of certain products, including vitamin A, vitamin E, and carotenoids, as well as several aroma ingredients.

In an update yesterday, BASF provided further details based on inspection results, repair progress, and confirmed delivery dates for replacement equipment. The company confirmed that production of aroma ingredients such as Pyranol, Methylionone 70, and DL-Menthol FG is expected to restart in the last week of October. Revised allocation volumes for these products will be communicated in the second half of November 2024. The remaining aroma ingredients will be brought back online gradually between April and June 2025.

As for nutrition ingredients, production of vitamin A is expected to resume in April 2025, with vitamin E and carotenoids following in July 2025. However, BASF noted that several months would be required after the restart to fully restore inventory levels and return to "business as usual."

In late August, BASF had provided a tentative​ timeline, estimating that production of vitamin A, vitamin E, and carotenoid products would not resume before January 2025.

The company reiterated yesterday that the latest timelines are based on current information and may be subject to further changes.

In September we heard about the broader risks of such supply chain disruptions and on how industry should develop contigency plans​ to ensure nutrition security.

Price impact 

Stefan Schmidinger, chief economist for markets and strategy at Kemiex, told us that price risks for vitamins E and A are expected to remain elevated for an extended period.

"Parts of the market were caught off guard, having anticipated a price normalization and production restart closer to the initially projected dates, rather than the current three to six month delay."

In the meantime, major manufacturers have ceased offering products as they reassess the situation, fueled by unconfirmed rumors that Chinese policymakers are allegedly restricting production volumes for the coming months, he said.

"While no severe shortages are expected over the next nine months, the balance of negotiating power has shifted in favor of sellers. For vitamin A, however, new entrants are set to broaden supply in the coming months. Share prices of Chinese producers have surged since yesterday. For dsm-firmenich, it is estimated that every €1/kg increase in vitamin E prices translates to an annualized €50m impact on EBITDA."

Related topics Vitamins & premixes Supply chain

Related news

Show more

Related products

show more

Unlock sensory innovation with AromatiQ™ technology

Unlock sensory innovation with AromatiQ™ technology

Content provided by Lonza | 20-Sep-2024 | Product Brochure

With 70% of consumers willing to pay a premium for a more enjoyable and memorable supplement experience, Lonza’s new AromatiQ™ technology enables brands...

Your guide to nutritional care innovation

Your guide to nutritional care innovation

Content provided by dsm-firmenich | 22-Aug-2024 | Insight Guide

The medical nutrition market is primed for innovation due to aging populations, chronic diseases, nutrition awareness and scientific advances. Our comprehensive...

Related suppliers

Follow us

Products

View more

Webinars